Ultra-deep sequencing leads to earlier and more sensitive detection of the tyrosine kinase inhibitor resistance mutation T315I in chronic myeloid leukemia.
about
Liquid biopsies in lung cancer-time to implement research technologies in routine care?Current trends in molecular diagnostics of chronic myeloid leukemia.Ponatinib as a Valid Alternative Strategy in Patients with Blast Crisis-Chronic Myeloid Leukemia Not Eligible for Allogeneic Stem Cells Transplantation and/or Conventional Chemotherapy: Report of a Case.Characteristics and mutation analysis of Ph-positive leukemia patients with T315I mutation receiving tyrosine kinase inhibitors.Imatinib resistance in chronic myeloid leukemia due to a rare mutation.
P2860
Ultra-deep sequencing leads to earlier and more sensitive detection of the tyrosine kinase inhibitor resistance mutation T315I in chronic myeloid leukemia.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
2016年论文
@zh
2016年论文
@zh-cn
name
Ultra-deep sequencing leads to ...... I in chronic myeloid leukemia.
@en
type
label
Ultra-deep sequencing leads to ...... I in chronic myeloid leukemia.
@en
prefLabel
Ultra-deep sequencing leads to ...... I in chronic myeloid leukemia.
@en
P2093
P2860
P50
P1433
P1476
Ultra-deep sequencing leads to ...... I in chronic myeloid leukemia.
@en
P2093
Constance Baer
Niroshan Nadarajah
Sarah Koch
Sonja Schindela
Wolfgang Kern
P2860
P304
P356
10.3324/HAEMATOL.2016.145888
P577
2016-04-21T00:00:00Z